Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have to agree @gmcc it is looking very bright.
Yes agree Vegas22 ( did say current paperwork ) - Indeed think Avacta future very bright indeed .
gmcc, nobody suggested they are selling Avacta tests,
ES pointed out there is some sort of link up
So maybe the future is brighter
Sorry -Documentation from Chinese site " It only recognizes the N protein and cannot detect the S protein " so current product paperwork on offer nothing to do with Avacta . However does not mean they may in the future offer via MEDUSA-19 - " AffiDX® SARS-CoV-2 Antigen Lateral Flow Test"
Anyway thought this article interesting
"Day 2 Antigen Test: Lateral Flow Test To Replace RT-PCR For Those Fully Vaccinated"
https://uk.news.yahoo.com/day-2-antigen-test-lateral-113000812.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&guce_referrer_sig=AQAAAF-kddC0Q851p80NaW02yWjaKG0lKfS1cvDSf1_ncPdSJg67fHkHi7qqH5rcL_k6NtISzpQj4F5PzEG2cOWfJYYYvhIAcP6hFA4q1KGlfgKY0Cp9OuQ-ahsu6-KnotEzdeoSRzuGyqs8PLjTR--b7KJV63gyEPqLLxwN3ao5BeU6
gje, not sure why any co would want to Nick Medusa's template,logo and phone no in order to sell covid tests
Think about it us as investors know who Medusa are the rest of the world doesn't, I can think of better companies who they'd be better imitating
From the product leaflet on their site:
'The Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test Kit is a chromatographic immunoassay intended for the qualitative detection of the nucleocapsid protein antigen from
SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab,saliva or nasal swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset. It only recognizes the N protein and cannot detect the S protein and its mutation structure. The test provides preliminary test results. Negative results do not preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision. For in vitro diagnostic use only. Summary The novel coronaviruses belong to the ß genus.COVID-19 is an acute respiratory
infectious disease. People are generally susceptible. Currently, the patients infected by novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation periodis 1 to 14 days,mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. Principle The Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test Kit is composed of novel Coronavirus monoclonal antibody 2 and goat anti- mouse IgG polyclonal antibody fixed in the nitrocellulose membrane and Novel Coronavirus monoclonal antibody 1 latex-labeled fixed in the release pad. The kit tests Novel Coronavirus SARS-CoV-2 N antigen in human
nasopharyngeal swabs , oropharyngeal swabs ,saliva or nasal swabs with the principle of double antibody sandwich method by latex immunochromatography. When a specimen is added to the sample well, the sample is first mixed with the colored latex-labeled novel coronavirus monoclonal antibody 1 on the release pad, and then migrate on the nitrocellulose membrane. If SARS-CoV-2 N protein antigen presents in the sample, these antigens will bind to coronavirus monoclonal antibody 1 labeled with color latex forming antigen antibodies complex. This complex migrates through nitrocellulose membrane by capillary action. When the complex is captured by the SARS-CoV-2 monoclonal antibody 2 to form a red colored band in the T line, which is a positive result. If no antigen presents in the sample, there will be no red band appearing in the testing region, this is a negative result. The internal control (C band) fixing with goat anti-mouse antibody should exhibit a red band regardless of whether antigen presents in the test.'
Actually, I will take some of that back, I was looking at it on a phone, and it's dreadful but better on a PC. So undecided
IMO, gje has it correct, ripped off site edited.
Why would an email link reveal a telephone number, hasn't even got a country code.
Place holder where menu icon should be
'Richard Hughes and Mahmud Kamani, Founders of Medusa19 commented:
“We immediately recognised the global opportunity to distribute the simple and unique saliva-based COVID-19 rapid test being developed by Avacta based on their unique and powerful Affimer platform.
Medusa19 will enable end-to-end supply of these tests on a global basis subject to regulatory approval and manufacturing capacity which will be key. The enormous, world-wide demand for these tests requires a robust and scalable platform which we are in the process of creating. Hundreds of millions of tests are required and this demand will continue.'
Is Jinwodu going to be manufacturing our test as well as distributing it???
If Medusa have global rights to distribute our test they're going to need access to huge production capacity and China appears to be the only place able to offer this.
However, this does fly in the face of UK made...or are they hanging their hat on the affimer being UK made...
All will be revealed no doubt in due course...
Thats great Vascular, we can be 'unknown' on the EU Ehrlich list; you have to laugh at procedures. Just hope 'is it us'
Been saying for last 12 months Medusa-19 absolute key, they can sell sand to the Arab and ice to the Eskimo in massive quantity.
And They didn’t get into this to just make and few hundred million a year :-)
Beijing Jinwofu Bioengineering Technology Co., Ltd
English /
Jinwofu press releases. This is the latest!
"The Novel Coronavirus (SARS-COV-2) antigen Rapid Test kit has been launched!"
The “COVID-19 Antigen Test Reagent” produced by Jinwofu company has been passed the EU CE certification, and It is also the first test reagent validated by China Food and Drug Control Research Institute.
Jinwofu Novel Coronavirus (SARS-COv-2) antigen Rapit Test Kit has been exported to many countries and has recently signed agreements with related foreign companies to reach cooperation. In order to promote the friendly cooperation of multi-country trade exchanges in the future!
http://www.jwfbio.com/en/
This is good detective work, but I’m going to play devil’s advocate here and suggest that whomever is behind jiabisen have just nicked Medusa19’s template, even down to the phone number and logo (at bottom of page), and there’s no further link between them.
I called up the number, and it did indeed take me to the medusa19 sales line, which is closed over the weekend. Will try on Monday and see if I can buy a batch of Jinwofu tests ;)
Thanks roundhowe. Good call by the way :).
beinthelead.....it wasn't www.jiabisen.com as this name was registered on the 2nd April 2021 through Alibaba Cloud Computing.
Wow - proper sleuthing. Thank you.
Probably dreaming - it’s been a long 12 months. But wasn’t this Chinese Medusa clone exposed last year?
AS did say would update the market when advised on the LFT home use submission --- "• Excellent progress being made towards self-test regulatory approval with Medusa19 with the submission of the regulatory documentation to a notified body in Europe."
Avacta already have professional use :
"Diagnostics
• There will be an ongoing global need for sensitive and reliable COVID-19 testing for many years.
• AffiDX SARS-CoV-2 antigen flow test with market leading performance CE marked for professional use.
• UK manufacturing capacity 2-3 million per month scalable in UK and abroad
Commercial traction building through direct sales and distributors in UK, EU and overseas in key markets such as APAC region."
Brilliant sleuthing thanks ,watch out Poirot.
Well we know now Medusa aren’t sitting waiting for HUA,
Global logistics are being put in place.
That paragraph is a bit of a giveaway I have to say. Hope we find out what is going on sooner rather than later.
Zhuoyue is founded in early 2020 to supply scalable COVID-19 testing solutions to help businesses and organizations rebuild confidence and trust with employees and customers.
Medusa website
Founded in early 2020 to supply scalable COVID-19 testing solutions to help businesses and organisations rebuild confidence and trust with employees and customers.
Good thinking medusa! Might even end up with a UK contract by going through a Chinese distributor :)
Thanks Energyshares - nice find appreciate you sharing all good news for AVCT .